Effct of Thymosin α1 Trangenic Synechococcus sp. PCC 7942 on T-Cell Subsets in Mice

刘仁海,章军,周克夫,徐虹,徐惠娟,楼士林,黄守杰

DOI: https://doi.org/10.3321/j.issn:0438-0479.2003.04.026

2003-01-01

Abstract:Human thymosin α1 gene had been expressed effectively in Synechococcus sp. PCC 7942 in our laboratory ,and in this experiment the effects of thymosin al transgenic Synechococcus sp. PCC 7942 on the T-cell subsets were characterized in mice. In light of the method of this experiment, six groups of mice were formed as follows: low dosage group, moderate dosage group, high dosage group, wild algae group, blank control group, and positive control group . Of these six groups, the first three were orally administrated with thymosin al transgenic Synechococcus sp PCC 7942, the dosage of which ranged over 0. 2 g/ kg, 0. 4 g/kg, 0. 6 g/kg respectively; the wild Algae group were in the same way fed with 0. 4 g/kg of wild Synechococcus sp PCC 7942, the blank control group with equal amount of physiological saline; and only the positive control group were intramuscularly injected 3. 2 mg/kg thymosin al. The results of this experiment demonstrate that thymosin al transgenic Synechococcus sp PCC 7942 can not only remarkably promote the level of CD3,but also notably upgrade the level of CD4 and significantly improve the ratio of CD4/ CD8, which, in this regard, indicate that thymosin al transgenic Synechococcus sp PCC 7942 can improve the immunocompetence in vivo.